Acta Cirúrgica Brasileira · 2011 · 21 citations · 16 references
MedicineInternal MedicineClinical PharmacologyGastroenterologyHemodynamic ManagementInflammatory Bowel DiseaseInflammatory Bowel Disease CareOxygen TherapyClinical RemissionHyperbaric ExposureHyperbaric InterventionInflammatory Bowel Disease TherapyOxygen Therapy Management
PURPOSE: Evaluate the application of Hyperbaric Oxygen Therapy (HBO) in patients with Crohn's disease (CD) refractory to pharmacologic therapy, who developed abdominal, anorectal or skin complications. METHODS: Fourteen selected patients with refractory CD and treated at the School of Medicine of Ribeirao Preto, University of Sao Paulo (FMRP-USP) and at the Center of Hyperbaric Medicine, São Paulo Hospital (CEMEHI) were submitted to HBO. RESULTS: Of the 14 patients evaluated, 11 had a satisfactory response. CONCLUSION: HBO has shown benefits in patients with CD refractory to pharmacologic therapy.
16
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
Stephen B. Hanauer, Brian G. Feagan, Gary R. Lichtenstein et al. · The Lancet · 2002 · 4.2K citations
European Cooperative Crohn's Disease Study (ECCDS): Results of drug treatment
H Malchow, Klaus Ewe, J W Brandes et al. · Gastroenterology · 1984 · 945 citations